Circulating calprotectin levels four months after severe and non-severe COVID-19
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Circulating calprotectin levels four months after severe and non-severe COVID-19 ; volume:23 ; number:1 ; day:3 ; month:10 ; year:2023 ; pages:1-9 ; date:12.2023
BMC infectious diseases ; 23, Heft 1 (3.10.2023), 1-9, 12.2023
- Urheber
-
Abu Hussein, N.
Machahua, C.
Ruchti, SC
Horn, MP
Piquilloud, L.
Prella, M.
Geiser, TK
von Garnier, C.
Funke-Chambour, M.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12879-023-08653-7
- URN
-
urn:nbn:de:101:1-2024020710364473031971
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 15.08.2025, 07:27 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Abu Hussein, N.
- Machahua, C.
- Ruchti, SC
- Horn, MP
- Piquilloud, L.
- Prella, M.
- Geiser, TK
- von Garnier, C.
- Funke-Chambour, M.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Cluster analysis unveils a severe persistent respiratory impairment phenotype 3-months after severe COVID-19
Circulating cytokines in predicting development of severe acute pancreatitis
Circulating nucleosomes as predictive markers of severe acute pancreatitis
Endotoxemia and circulating bacteriome in severe COVID-19 patients
Circulating cytokines in predicting development of severe acute pancreatitis
Severe bullous pemphigoid in a 4‐month‐old infant
Association of circulating calprotectin with lipid profile in axial spondyloarthritis
Severe
Circulating calprotectin (S100A8/A9) is higher in rheumatoid arthritis patients that relapse within 12 months of tapering anti-rheumatic drugs
Pulmonary Recovery 12 Months after Non-Severe and Severe COVID-19: The Prospective Swiss COVID-19 Lung Study
Septime Sévère
Severe malaria
Cluster analysis unveils a severe persistent respiratory impairment phenotype 3-months after severe COVID-19
Circulating cytokines in predicting development of severe acute pancreatitis
Circulating nucleosomes as predictive markers of severe acute pancreatitis
Endotoxemia and circulating bacteriome in severe COVID-19 patients
Circulating cytokines in predicting development of severe acute pancreatitis
Severe bullous pemphigoid in a 4‐month‐old infant
Association of circulating calprotectin with lipid profile in axial spondyloarthritis
Severe
Circulating calprotectin (S100A8/A9) is higher in rheumatoid arthritis patients that relapse within 12 months of tapering anti-rheumatic drugs
Pulmonary Recovery 12 Months after Non-Severe and Severe COVID-19: The Prospective Swiss COVID-19 Lung Study
Septime Sévère
Severe malaria
Cluster analysis unveils a severe persistent respiratory impairment phenotype 3-months after severe COVID-19
Circulating cytokines in predicting development of severe acute pancreatitis
Circulating nucleosomes as predictive markers of severe acute pancreatitis
Endotoxemia and circulating bacteriome in severe COVID-19 patients
Circulating cytokines in predicting development of severe acute pancreatitis
Severe bullous pemphigoid in a 4‐month‐old infant
Association of circulating calprotectin with lipid profile in axial spondyloarthritis
Severe
Circulating calprotectin (S100A8/A9) is higher in rheumatoid arthritis patients that relapse within 12 months of tapering anti-rheumatic drugs
Pulmonary Recovery 12 Months after Non-Severe and Severe COVID-19: The Prospective Swiss COVID-19 Lung Study
Septime Sévère